Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Sex- and suicide-specific alterations in the kynurenine pathway in the anterior cingulate cortex in major depression

    Major depressive disorder (MDD) is a serious psychiatric disorder that in extreme cases can lead to suicide. Evidence suggests that alterations in the kynurenine pathway (KP) contribute to the pathology of MDD...

    Samara J. Brown, Katerina Christofides, Christin Weissleder in Neuropsychopharmacology (2024)

  2. Article

    Open Access

    Correction: Obesity and brain structure in schizophrenia – ENIGMA study in 3021 individuals

    Sean R. McWhinney, Katharina Brosch, Vince D. Calhoun in Molecular Psychiatry (2024)

  3. No Access

    Article

    A path to novel, effective treatments for schizophrenia

    Thomas W. Weickert, Cynthia Shannon Weickert in Neuropsychopharmacology (2024)

  4. No Access

    Article

    Cytomegalovirus antibodies are associated with mood disorders, suicide, markers of neuroinflammation, and microglia activation in postmortem brain samples

    Cytomegalovirus (CMV) is a common, neurotrophic herpesvirus that can be reactivated by inflammation and cause central nervous system disease. We hypothesize that CMV may contribute to the neuroinflammation tha...

    Haixia Zheng, Maree J. Webster, Cynthia Shannon Weickert in Molecular Psychiatry (2023)

  5. Article

    Open Access

    Perturbed iron biology in the prefrontal cortex of people with schizophrenia

    Despite loss of grey matter volume and emergence of distinct cognitive deficits in young adults diagnosed with schizophrenia, current treatments for schizophrenia do not target disruptions in late maturational...

    Amit Lotan, Sandra Luza, Carlos M. Opazo, Scott Ayton in Molecular Psychiatry (2023)

  6. Article

    Open Access

    Single-nucleus RNA sequencing of midbrain blood-brain barrier cells in schizophrenia reveals subtle transcriptional changes with overall preservation of cellular proportions and phenotypes

    The midbrain is an extensively studied brain region in schizophrenia, in view of its reported dopamine pathophysiology and neuroimmune changes associated with this disease. Besides the dopaminergic system, the...

    Sofía Puvogel, Astrid Alsema, Laura Kracht, Maree J. Webster in Molecular Psychiatry (2022)

  7. Article

    Open Access

    Correction: Obesity and brain structure in schizophrenia – ENIGMA study in 3021 individuals

    Sean R. McWhinney, Katharina Brosch, Vince D. Calhoun in Molecular Psychiatry (2022)

  8. Article

    Open Access

    Obesity and brain structure in schizophrenia – ENIGMA study in 3021 individuals

    Schizophrenia is frequently associated with obesity, which is linked with neurostructural alterations. Yet, we do not understand how the brain correlates of obesity map onto the brain changes in schizophrenia....

    Sean R. McWhinney, Katharina Brosch, Vince D. Calhoun in Molecular Psychiatry (2022)

  9. Article

    Open Access

    Cell type-specific manifestations of cortical thickness heterogeneity in schizophrenia

    Brain morphology differs markedly between individuals with schizophrenia, but the cellular and genetic basis of this heterogeneity is poorly understood. Here, we sought to determine whether cortical thickness ...

    Maria A. Di Biase, Michael P. Geaghan, William R. Reay in Molecular Psychiatry (2022)

  10. Article

    Open Access

    Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases

    Elevations in plasma levels of pro-inflammatory cytokines and C-reactive protein (CRP) in patient blood have been associated with impairments in cognitive abilities and more severe psychiatric symptoms in peop...

    Caitlin E. Murphy, Adam K. Walker, Maryanne O’Donnell in Translational Psychiatry (2022)

  11. Article

    Open Access

    A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone

    Inflammation regulates neurogenesis, and the brains of patients with schizophrenia and bipolar disorder have reduced expression of neurogenesis markers in the subependymal zone (SEZ), the birthplace of inhibit...

    Hayley F. North, Christin Weissleder, Janice M. Fullerton in Translational Psychiatry (2021)

  12. No Access

    Article

    A new suspect in the unsolved case of neuroinflammation in schizophrenia

    Caitlin E. Murphy, Cynthia Shannon Weickert in Molecular Psychiatry (2021)

  13. No Access

    Article

    Reduced adult neurogenesis is associated with increased macrophages in the subependymal zone in schizophrenia

    Neural stem cells in the human subependymal zone (SEZ) generate neuronal progenitor cells that can differentiate and integrate as inhibitory interneurons into cortical and subcortical brain regions; yet the ex...

    Christin Weissleder, Hayley F. North, Maina Bitar in Molecular Psychiatry (2021)

  14. Article

    Open Access

    Neuroinflammation in schizophrenia: the role of nuclear factor kappa B

    Neuroinflammation, particularly in the dorsolateral prefrontal cortex, is well-established in a subset of people with schizophrenia, with significant increases in inflammatory markers including several cytokin...

    Caitlin E. Murphy, Adam K. Walker, Cynthia Shannon Weickert in Translational Psychiatry (2021)

  15. Article

    Open Access

    Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation

    The pathophysiology of dopamine dysregulation in schizophrenia involves alterations at the ventral midbrain level. Given that inflammatory mediators such as cytokines influence the functional properties of mid...

    Tertia D. Purves-Tyson, Ulrike Weber-Stadlbauer, Juliet Richetto in Molecular Psychiatry (2021)

  16. Article

    Open Access

    Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia

    The kynurenine pathway (KP) of tryptophan (TRP) catabolism links immune system activation with neurotransmitter signaling. The KP metabolite kynurenic acid (KYNA) is increased in the brains of people with schi...

    Jochen Kindler, Chai K. Lim, Cynthia Shannon Weickert in Molecular Psychiatry (2020)

  17. Article

    Open Access

    Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation

    Elevated pro-inflammatory cytokines exist in both blood and brain of people with schizophrenia but how this affects molecular indices of the blood–brain barrier (BBB) is unclear. Eight mRNAs relating to BBB fu...

    Helen Q. Cai, Vibeke S. Catts, Maree J. Webster, Cherrie Galletly in Molecular Psychiatry (2020)

  18. No Access

    Article

    Circular RNA biogenesis is decreased in postmortem cortical gray matter in schizophrenia and may alter the bioavailability of associated miRNA

    Circular RNAs (circRNAs) are a covalently closed subclass of non-coding RNA molecules formed by back splicing of linear precursor RNA. These molecules are relatively stable and particularly abundant in the mam...

    Ebrahim Mahmoudi, Chantel Fitzsimmons, Michael P. Geaghan in Neuropsychopharmacology (2019)

  19. Article

    Open Access

    Temporal proteomic profiling of postnatal human cortical development

    Healthy cortical development depends on precise regulation of transcription and translation. However, the dynamics of how proteins are expressed, function and interact across postnatal human cortical developme...

    Michael S. Breen, Sureyya Ozcan, Jordan M. Ramsey, Zichen Wang in Translational Psychiatry (2018)

  20. Article

    Open Access

    Decreased Brain pH as a Shared Endophenotype of Psychiatric Disorders

    Although the brains of patients with schizophrenia and bipolar disorder exhibit decreased brain pH relative to those of healthy controls upon postmortem examination, it remains controversial whether this findi...

    Hideo Hagihara, Vibeke S Catts, Yuta Katayama, Hirotaka Shoji in Neuropsychopharmacology (2018)

previous disabled Page of 2